GFM Network News






Roundup cancer verdict sends Bayer shares sliding

    Frankfurt | Reuters — Bayer shares plunged as much as 14 per cent on Monday, losing about US$14 billion in value, after newly acquired Monsanto was ordered to pay US$289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict



Bayer wins U.S. nod for Monsanto deal to create ag giant

Frankfurt/Washington | Reuters — Bayer won U.S. approval for its planned takeover of Monsanto after agreeing to sell about US$9 billion in assets, clearing a major hurdle for the US$62.5 billion deal that will create by far the largest seeds and pesticides maker. Makan Delrahim, who heads the U.S. Justice Department’s (DoJ) antitrust division, said

Singapore firm hikes Bayer stake in share sale

Frankfurt | Reuters — German drugmaker Bayer is raising three billion euros (C$4.67 billion) toward its planned US$62.5 billion takeover of seed and chemical firm Monsanto by selling a 3.6 per cent stake to Singapore’s state investment company Temasek. Bayer said it had struck a deal with Temasek under which it would issue shares with

Bayer to sell digital farming business to BASF

Frankfurt | Reuters — Germany’s Bayer plans to sell its digital farming business to BASF as part of changes to concessions it has offered to win over antitrust regulators for its proposed takeover of Monsanto . Bayer, which had previously only agreed to grant a licence to competitors, said on Wednesday that as part of


Bayer petitions Russian antitrust watchdog for more time in Monsanto case

Frankfurt/Moscow | Reuters — Bayer has taken Russia’s competition regulator to court over the watchdog’s investigation into the company’s planned takeover of Monsanto, a further hiccup in the US$64 billion deal amid intense antitrust scrutiny. A Bayer spokesman said the German company was petitioning the court in Russia to be given more time to discuss